Silibinin inhibits LPS-induced macrophage activation by blocking p38 MAPK in RAW 264.7 cells

63Citations
Citations of this article
44Readers
Mendeley users who have this article in their library.

Abstract

We demonstrate herein that silibinin, a polyphenolic flavonoid compound isolated from milk thistle (Silybum marianum), inhibits LPS-induced activation of macrophages and production of nitric oxide (NO) in RAW 264.7 cells. Western blot analysis showed silibinin inhibits iNOS gene expression. RT-PCR showed that silibinin inhibits iNOS, TNF-α, and IL1β. We also showed that silib-inin strongly inhibits p38 MAPK phosphorylation, whereas the ERK1/2 and JNK pathways are not inhibited. The p38 MAPK inhibitor abrogated the LPS-induced nitrite production, whereas the MEK-1 inhibitor did not affect the nitrite production. A molecular modeling study proposed a binding pose for silibinin targeting the ATP binding site of p38 MAPK (1OUK). Collectively, this series of experiments indicates that silibinin inhibits macrophage activation by blocking p38 MAPK signaling. © 2013 The Korean Society of Applied Pharmacology.

Cite

CITATION STYLE

APA

Youn, C. K., Park, S. J., Lee, M. Y., Cha, M. J., Kim, O. H., You, H. J., … Jeon, Y. J. (2013). Silibinin inhibits LPS-induced macrophage activation by blocking p38 MAPK in RAW 264.7 cells. Biomolecules and Therapeutics, 21(4), 258–263. https://doi.org/10.4062/biomolther.2013.044

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free